Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: GRYPHON BIO INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-09-26 to 2025-12-24
Current total value of award: $749437
Description: FEASIBILITY STUDY OF A SINGLE PLATFORM SOLUTION FOR BLOOD TESTING OF TRAUMATIC BRAIN INJURY BIOMARKERS.